Superworth

Large drugmakers with the lowest price to sales ratio

Market value divided by revenue over the last twelve months. As of .

Ranked
160
of 411 large drugmakers we cover
Median
4.6×
Lowest
0.0×
JAGX
Range
0.0× to 98.0×
median 4.6×
0.2×74.8×
#CompanyP/SNet marginRevenue growth (TTM)Market cap
1JAGXJaguar Health0.0×n/m+135.5%$304.6K
2SBFMSunshine Biopharma0.0×−16.5%−2.7%$533.1K
3KPTIKaryopharm Therapeutics0.0×n/m+6.8%$2.5M
4ORGOOrganogenesis0.2×−18.4%+6.5%$97.2M
5BHCBausch Health Companies0.3×−7.6%+10.8%$3B
6BFRIBiofrontera0.3×−13.8%+17.8%$12.9M
7HCWBHCW Biologics0.3×−83.0%n/m$2.1M
8AYTUAytu Biopharma0.4×−24.8%−13.3%$21.1M
9HRTXHeron Therapeutics0.4×−22.5%+1.0%$56M
10RMTIRockwell Medical0.4×−7.3%−21.1%$27.9M
11LFVNLifevantage0.4×2.8%−20.1%$73.5M
12EBSEmergent BioSolutions0.4×−23.0%−17.7%$330.2M
13NATRNatures Sunshine Products0.4×3.7%+6.8%$211.5M
14PRGOPERRIGO0.5×−41.9%−4.2%$2.2B
15OGNOrganon0.6×3.5%−3.2%$3.6B
16ELABPMGC0.7×n/mn/m$1.7M
17XLOXilio Therapeutics0.7×n/mn/m$46.2M
18MGNXMacrogenics0.9×−8.7%+11.7%$148.4M
19AKBAAkebia Therapeutics0.9×−13.5%+7.5%$196.3M
20CRMDCorMedix0.9×40.5%+280.5%$420.1M
21COLLCollegium Pharmaceutical1.0×5.9%+14.3%$770.9M
22SRPTSarepta Therapeutics1.0×−6.9%−20.4%$1.9B
23VNDAVanda Pharmaceuticals1.0×n/m+8.1%$234.6M
24PAHCPhibro Animal Health1.0×6.6%+17.1%$1.6B
25GOSSGossamer Bio1.1×n/m+32.4%$57.7M
26SPROSpero Therapeutics1.3×15.7%−3.3%$60.6M
27AMRNAmarin Corp Plc1.4×−14.6%−15.1%$256.2M
28CELUCelularity1.4×n/m−58.1%$26M
29IRWDIronwood Pharmaceuticals1.5×33.4%+26.2%$571.7M
30XBIOXenetic Biosciences1.5×−75.9%+33.3%$4.8M
31EOLSEvolus1.5×−10.8%+13.9%$472.9M
32ARVNArvinas1.6×2.9%−15.0%$491.7M
33AMPHAmphastar Pharmaceuticals1.6×10.8%+1.0%$1.1B
34ENSCEnsysce Biosciences1.7×n/m−39.3%$7.4M
35ANIPANI Pharmaceuticals1.7×11.1%+30.9%$1.6B
36ARDXArdelyx1.7×−12.4%+16.8%$755M
37PHATPhathom Pharmaceuticals1.7×−30.2%+86.8%$480.8M
38VRCAVerrica Pharmaceuticals1.8×n/m+106.2%$55.1M
39PCRXPacira BioSciences1.9×2.0%+5.7%$1.5B
40SCYXScynexis2.0×−53.3%n/m$37.9M
41DERMJourney Medical2.0×−9.0%+20.9%$135.2M
42CPIXCumberland Pharmaceuticals2.0×−34.9%−1.1%$63.2M
43AMRXAmneal Pharmaceuticals2.1×5.0%+9.3%$6.5B
44PBHPrestige Consumer Healthcare2.1×15.6%−1.4%$2.4B
45OPKOpko Health2.2×−12.4%−11.5%$1.3B
46RAREUltragenyx Pharmaceutical2.2×−81.7%+17.4%$1.6B
47PBYIPuma Biotechnology2.3×11.6%−2.9%$525.5M
48HRMYHarmony Biosciences2.3×18.9%+24.3%$2.2B
49ELANElanco Animal Health2.4×−4.0%+12.0%$12B
50SUPNSupernus Pharmaceuticals2.4×−5.1%+26.9%$2.1B
51ADCTADC Therapeutics SA2.5×n/m+3.0%$196.6M
52BOLTBolt Biotherapeutics2.6×n/m+12.8%$12M
53BMYBristol-Myers Squibb2.6×18.5%+4.2%$128.7B
54VTVTvTv Therapeutics2.6×−12.9%n/m$95.5M
55SPRYARS Pharmaceuticals2.6×n/m+4.1%$303.3M
56PFEPfizer2.8×6.8%−0.2%$176B
57LABStandard Biotools2.8×n/m−23.6%$239.4M
58SXTP60 Degrees Pharmaceuticals2.9×n/m+73.2%$3.2M
59GERNGeron2.9×−33.1%+24.4%$596.9M
60MNKDMannkind3.0×−11.1%+30.5%$1.2B
61JAZZJazz Pharmaceuticals3.0×20.4%+12.6%$13.9B
62TNXPTonix Pharmaceuticals3.0×n/m+196.0%$88.3M
63BCYCBicycle Therapeutics3.0×n/m+194.7%$253.7M
64ACADAcadia Pharmaceuticals3.1×33.4%+11.8%$3.5B
65INDVIndivior Pharmaceuticals3.1×32.8%+16.3%$4.3B
66BMRNBiomarin Pharmaceutical3.3×2.1%+11.2%$11.1B
67RIGLRigel Pharmaceuticals3.4×n/m+3.3%$943.9M
68FHTXFoghorn Therapeutics3.4×n/m+52.0%$126.5M
69INVAInnoviva3.5×81.2%+18.8%$1.5B
70BIIBBiogen3.7×8.3%+0.3%$37B
71CUECue Biopharma3.7×n/mn/m$141.1M
72HROWHarrow3.8×−13.5%+21.1%$1.1B
73SIGASiga Technologies4.0×−5.2%−70.1%$212M
74NRIXNurix Therapeutics4.0×42.0%n/m$2.8B
75ABUSArbutus Biopharma4.4×84.2%n/m$791.4M
76PTCTPTC Therapeutics4.4×−9.2%−35.1%$5.1B
77ZVRAZevra Therapeutics4.4×42.8%+119.4%$599.8M
78CYRXCryoport4.4×−20.1%+12.1%$822M
79GYREGyre Therapeutics4.4×−15.5%+13.5%$527.4M
80ALKSAlkermes plc.4.5×4.0%+10.8%$7.5B
81LGVNLongeveron4.6×n/m−42.7%$5.5M
82SNDXSyndax Pharmaceuticals4.6×−87.5%+159.7%$1.2B
83ENTAEnanta Pharmaceuticals4.7×−96.9%+0.7%$303.8M
84ASMBAssembly Biosciences5.3×−0.1%+125.1%$397.2M
85MRKMerck5.3×3.6%+4.9%$359.5B
86ZLABZai Lab5.4×−41.9%+5.1%$2.4B
87XERSXeris Biopharma5.5×−5.1%+36.3%$1.9B
88TXMDTherapeuticsMD6.4×−6.6%+27.8%$20.9M
89JNJJohnson & Johnson6.5×n/m+7.8%$650.2B
90AMGNAmgen6.6×23.0%+9.1%$252.3B
91CPHIChina Pharma6.7×n/m−11.0%$26.1M
92AUPHAurinia Pharmaceuticals6.7×97.7%+21.0%$2.2B
93GILDGilead Sciences6.9×−12.5%+6.5%$212.5B
94SDGRSchrodinger7.6×−21.0%+8.9%$2B
95LPCNLipocine7.6×n/m−62.7%$12M
96ABBVAbbVie7.7×15.7%+10.7%$511.6B
97MDGLMadrigal Pharmaceuticals7.8×−25.3%+149.0%$10B
98PRTAProthena Corp Public7.8×−80.7%n/m$425.6M
99IONSIonis Pharmaceuticals7.8×−64.7%−7.4%$6.9B
100TVTXTravere Therapeutics7.9×−7.4%+49.4%$4.6B

The first 100 of 160.

Not ranked: 92 with not a meaningful number, 61 with a quarter missing, 11 with no price to sales (not meaningful for banks and some insurers), 8 with a value too high to mean anything, 4 with a value above 100× (too small a base to compare). 75 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

P/S for other groups

Other rankings of large drugmakers

The group